Ratchet Pharma Private Limited

Ratchet Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2013PTC249940 Incorporated 28 March 2013 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.66 Cr
▲ 3% YoY
Net profit · FY 2025
₹83,148
Net margin 0.5%
EBITDA · FY 2025
₹3.68 Lakh
EBITDA margin 2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Ratchet Pharma Private Limited

Data last updated:

Ratchet Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2013PTC249940. Its GSTIN is 06AAHCR1447G1ZH (Haryana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kanchan Vasudev and Jatin Chawla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No – 974A F/F Ward No.7 Meharauli Near Dcm Wali Gali, New Delhi, Delhi, India – 110030.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.66 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹83,148 (net margin 0.5%) and EBITDA of ₹3.68 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ratchetindia.com.

Company details

CIN U51909DL2013PTC249940
Registration Number 249940
Incorporation Date 28 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Ratchet Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is ratchetindia.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H. No – 974A F/F Ward No.7 Meharauli Near Dcm Wali Gali, New Delhi, Delhi, India – 110030
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ratchet Pharma Private Limited, buy the company report.

Comprehensive company report
Ratchet Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ratchet Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ratchet Pharma Private Limited, buy the company report.

Financials of Ratchet Pharma Private Limited

FY 2025 filings available

Ratchet Pharma Private Limited reported revenue of ₹1.66 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹1.66 Cr ▲ 3%
Net profit · FY 2025
₹83,148 margin 0.5%
EBITDA · FY 2025
₹3.68 Lakh margin 2.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 5%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 23%
5 years · compounded
▲ 38%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 3% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.68 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹83,148
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.2%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ratchet Pharma Private Limited, buy the company report.

Board of directors of Ratchet Pharma Private Limited

Ratchet Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Kanchan VasudevDirector28 Mar 201313 Years 6 MonthsCurrent
Jatin ChawlaDirector28 Mar 201313 Years 6 MonthsCurrent

Peer comparison

Ratchet Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Adelson Pharma Private Limited₹1.67 Cr (FY 2017)Jaipur, Rajasthan, India
El Shaddai Healthcare Private Limited₹1.66 Cr (FY 2024)-37.0%Chennai, Tamil Nadu, India
Ratchet Pharma Private Limitedthis company₹1.66 Cr (FY 2025)₹83,1480.5%3.0%New Delhi, Delhi, India
Kinsap Medisciences Private Limited₹1.66 Cr (FY 2025)-36.0%Green Park, Gujarat, India
Zerdia Healthcare Private Limited₹1.66 Cr (FY 2025)-8.0%Ambala Cantt, Haryana, India
Biomexon Pharmaceuticals Private Limited₹1.66 Cr (FY 2021)Delhi, India

To see the full peer comparison of Ratchet Pharma Private Limited, buy the company report.

Auditor

Ratchet Pharma Private Limited is audited by ANIRUDH JINDAL & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
ANIRUDH JINDAL & COFY 2021021006N

Shareholding

The shareholding of Ratchet Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ratchet Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ratchet Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ratchet Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAHCR1447G1ZHHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Ratchet Pharma Private Limited, buy the company report.

Recent activity

Ratchet Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Jatin Chawla was appointed as Director on 28 Mar 2013.

AGM
Ratchet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ratchet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Jatin Chawla was appointed as Director.
Appointed
Kanchan Vasudev was appointed as Director.
Incorporation
28 Mar 2013
Ratchet Pharma Private Limited was registered on 28 Mar 2013 with Roc Delhi & aged 13 years 6 months as per MCA records.

Frequently asked questions

Ratchet Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2013 (13+ years old) and is registered under CIN U51909DL2013PTC249940.

Ratchet Pharma has 2 current directors:

The latest financial statements of Ratchet Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ratchet Pharma is 06AAHCR1447G1ZH, registered in Haryana.

The CIN (Corporate Identification Number) of Ratchet Pharma is U51909DL2013PTC249940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ratchet Pharma was incorporated on 28 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ratchet Pharma by revenue are Adelson Pharma Private Limited, El Shaddai Healthcare Private Limited, Kinsap Medisciences Private Limited, Zerdia Healthcare Private Limited, Biomexon Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Jatin Chawla was appointed as Director on 28 Mar 2013. Kanchan Vasudev was appointed as Director on 28 Mar 2013.

Ratchet Pharma can be reached through the website ratchetindia.com. Its registered office is in New Delhi, Delhi, India.

The registered office of Ratchet Pharma is at H. No – 974A FF Ward No.7 Meharauli Near Dcm Wali Gali, New Delhi, Delhi, India – 110030.

Ratchet Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.